Varda Space Industries · 1 day ago
Senior Scientist, Drug Substance Development
Varda is a company focused on developing commercial space infrastructure, including in-orbit pharmaceutical processing. The Senior Scientist will lead efforts in improving therapeutics with microgravity, overseeing drug substance development and collaborating with engineers and scientists.
AerospaceManufacturingProduct Design
Responsibilities
Serve as technical lead for pharmaceutical development projects
The candidate will be responsible for supporting drug substance development including characterization of materials, crystallization screening and early-stage process characterization
Responsibilities include design, planning, and hands-on execution of laboratory studies
Drug substance characterization spans solid-state, physicochemical, and particle analysis
Collaborate with process engineers and analytical development scientists
Qualification
Required
Ph.D. degree in materials science, chemical engineering, organic chemistry, biochemistry with 3+ years of industry experience or M.S. degree in related field with 6+ years of industry experience
Experienced in drug substance development of small molecules (solvent screen, form screening and selection, stability studies)
Preferred
Ph.D. degree in materials science, chemical engineering, organic chemistry, biochemistry with 5+ years of industry experience
Experience with cradle-to-crave development from early R&D through commercialization
Demonstrated expertise in small molecule crystallography, including structural determination
Benefits
Exciting team of professionals at the top of their field working by your side
Equity in a fully funded space startup with potential for significant growth (interns excluded)
401(k) matching (interns excluded)
Unlimited PTO (interns excluded)
Health insurance, including Vision and Dental
Lunch and snacks provided on site every day. Dinners provided twice a week.
Maternity / Paternity leave (interns excluded)
Company
Varda Space Industries
Low Earth orbit is open for business.
Funding
Current Stage
Growth StageTotal Funding
$328.02MKey Investors
Alumni VenturesCaffeinated CapitalKhosla Ventures
2025-07-10Series C· $187M
2024-12-19Series C
2024-04-05Series B· $90M
Recent News
Business Insider
2025-12-25
2025-12-17
Company data provided by crunchbase